Publicaciones en las que colabora con Joaquín del Río Zambrana (37)

2009

  1. Effects of neonatal stress on markers of synaptic plasticity in the hippocampus: Implications for spatial memory

    Hippocampus, Vol. 19, Núm. 12, pp. 1222-1231

  2. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: Involvement of the HPA axis

    Psychoneuroendocrinology, Vol. 34, Núm. 10, pp. 1495-1505

2008

  1. Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats

    Neuroscience, Vol. 154, Núm. 4, pp. 1218-1226

  2. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: Effect of antidepressant treatment

    Psychopharmacology, Vol. 199, Núm. 1, pp. 1-14

2007

  1. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats

    Psychoneuroendocrinology, Vol. 32, Núm. 3, pp. 256-266

  2. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1)

    European Journal of Neuroscience, Vol. 25, Núm. 1, pp. 281-290

2004

  1. New 3-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT 1A serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 59, Núm. 7, pp. 499-501

2003

  1. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats

    Psychopharmacology, Vol. 169, Núm. 1, pp. 35-41

2002

  1. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors

    European Journal of Pharmacology, Vol. 442, Núm. 1-2, pp. 63-71

  2. GABAA receptor antagonists enhance cortical acetylcholine release induced by 5-HT3 receptor blockade in freely moving rats

    Brain Research, Vol. 956, Núm. 1, pp. 81-85

  3. New 3-[4-(3-substituted phenyl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)-propanol derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 57, Núm. 8, pp. 515-518

  4. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-2-yl)propane derivatives with dual action at 5-HT1a serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 57, Núm. 6, pp. 355-357

  5. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT1A receptors

    Journal of Medicinal Chemistry, Vol. 45, Núm. 19, pp. 4128-4139

2001

  1. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants

    Journal of Medicinal Chemistry, Vol. 44, Núm. 3, pp. 418-428

  2. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

    European Journal of Medicinal Chemistry, Vol. 36, Núm. 1, pp. 55-61

2000

  1. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin- 1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: Serotonin reuptake inhibition and 5-HT(1A) receptor antagonism

    Farmaco, Vol. 55, Núm. 5, pp. 345-353

  2. Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: A comparison with MDMA

    Pharmacology Biochemistry and Behavior, Vol. 65, Núm. 2, pp. 233-240

1999

  1. α-Lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

    NeuroReport, Vol. 10, Núm. 17, pp. 3675-3680

1998

  1. Differential interaction between 5-HT3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices

    Brain Research, Vol. 801, Núm. 1-2, pp. 228-232

  2. MDMA ('Ecstasy') enhances 5-HT(1A) receptor density and 8-OH-DPAT- induced hypothermia: Blockade by drugs preventing 5-hydroxytryptamine depletion

    European Journal of Pharmacology, Vol. 346, Núm. 2-3, pp. 181-188